Early Catheter Removal for Urogynecologic Surgery
(CARES2 Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that early removal of urinary catheters can reduce urinary tract infections and improve recovery after surgery. For example, studies found that early catheter removal after cesarean delivery and rectal cancer surgery led to fewer urinary symptoms and infections, suggesting similar benefits could apply to urogynecologic surgery.
12345Research suggests that early removal of urinary catheters is generally safe and may reduce the risk of urinary tract infections and other complications. Studies have shown that early removal can lead to fewer urinary symptoms and shorter hospital stays without increasing adverse events.
34567Early catheter removal is unique because it involves taking out the urinary catheter soon after surgery, which can help reduce the risk of urinary tract infections and speed up recovery. This approach contrasts with traditional methods that often leave the catheter in place for a longer period.
12358Eligibility Criteria
This trial is for women who have had prolapse or anti-incontinence surgery and can't empty their bladder properly before leaving the hospital. It's not for those who don't speak English, are pregnant, needed catheterization before surgery, got urethral injections, or had complications during surgery needing longer catheter use.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment/Intervention
Participants undergo urogynecologic surgery and are randomized to catheter removal on POD1 or POD3-4
Postoperative Monitoring
Participants are monitored for voiding symptoms and complications, with a phone call at week 2 and an office visit at week 6
Follow-up
Participants are monitored for postoperative complications such as UTI or urinary retention